Systems Oncology

1 follower

‌

Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance.

Industries

Headquarters

Employees

Links

Org chart

Spyro Mousses

Co-Founder & Chief Executive Officer

Spyro Mousses

Collapse

Andrew Matricaria

CFO

Daniel D. Von Hoff

Co-Founder & Chief Clinical Strategist

Marvin O’Ketch

Associate Director, Immunobiology

David Lee

Lab Manager & Senior Scientist

Lizette Castano

Research Associate II

Robert G. Petit II

Drug Development Advisor

Katy Marhenke

Director, Business Development Operations

Alex Lukianov

Member Board Of Directors

Teams

Leadership Team

3 members

Scientific Advisors

9 members

Research and Development

4 members

Similar companies

Inceptive

5 followers

Forge Biologics

2 followers

Vaxcyte

2 followers

Hillevax

2 followers

Kyverna Therapeutics

5 followers

Obsidian Therapeutics

1 follower

Cargo

1 follower

Chroma Medicine

1 follower

Slingshot Biosciences

1 follower

Araceli Biosciences

1 follower

Generate Biomedicines

3 followers

Discover companies